Technical Data
Phosphodiesterase 3A (Phosphodiesterase 3A cGMP-inhibited, PDE3A, cGMP-inhibited 3' 5'-cyclic Phosphodiesterase A, Cyclic GMP-inhibited Phosphodiesterase A, CGI-PDE A, CGI-PDE, Human cGMP-inhibited cAMP Phosphodiesterase mRNA)
Cellular Localization: Cell Membrane

Positive Control: Tested with Jurkat cell extract.

Suitable for use in Western Blot and Immunoprecipitation. Other applications not tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot Store at -20C. Aliquots are stable for at least 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
PabIgGAffinity Purified
100ug-20CBlue IceHumanGoat
Synthetic peptide (selective for only PDE3A variant).
Purified by immunoaffinity chromatography.
0.02% Sodium Azide
Does not cross react with PDE4B variants nor with any other PDEs. Species Crossreactivity: Human, Mouse, Rat and canine.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
Meacci E et al. Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase. Proc Natl Acad Sci U S A 89:3721-5 (1992). Farooqui SM et al. Antibodies against synthetic peptides predicted from the nucleotide sequence of D2 receptor recognize native dopamine receptor protein in rat striatum. J Neurochem 57:1363-9 (1991).